Webinar
Wound

Skin Substitute Reimbursement: What’s coming in 2026 and what providers need to know

Learn how to translate policy into day‑one operational steps for wound centers and physician offices.

What you’ll learn:
CMS’s CY 2026 rules align the Hospital Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) for the treatment of skin substitutes to reduce waste, fraud, and abuse and to remove payment‑driven site‑of‑service incentives.

  • How OPPS/PFS unification affects payment, scheduling, and care pathways January 1, 2026
  • How Kerecis products fit within this unified framework and current coverage policies
  • DFU & VLU evidence highlights you can reference in documentation
  • Where LCDs are active, how WISeR is applied, and what that means state‑by‑state
  • Documentation & prior‑auth essentials to minimize delays and denials

Who Should Attend:

  • Wound‑care leaders from clinics, hospital outpatient facilities and ambulatory care centers
  • Vascular surgeons
  • Plastics surgeons
  • Podiatrists
  • Hospital revenue‑cycle teams
  • Clinic managers
  • Coding and compliance staff

Educational policy briefing only; no pricing, contracting, or inducements will be discussed. Coverage varies by MAC and LCD; attendees should consult their local policies.

Speakers

  • Speaker: Jeffrey Lehrman, DPM Health Policy/LCD Specialist
  • Speaker: Gunnar Johannsson, MD SVP & Medical Director, Kerecis
  • Moderator: Ryan Mathis, MD Director of Global Medical Policy, Kerecis

 

 

Date & Time

November 20, 2025
6:00 pm
EST

Need more information?

From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory clearance in the United States, Europe, and beyond.

© 2010 – 2025 Kerecis. All Rights Reserved